Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Up 1% – Should You Buy?

Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) shot up 1% during trading on Wednesday . The company traded as high as $31.72 and last traded at $31.59. 32,622 shares changed hands during mid-day trading, an increase of 28% from the average session volume of 25,565 shares. The stock had previously closed at $31.29.

Roundhill GLP-1 & Weight Loss ETF Stock Up 1.0%

The company has a market cap of $52.44 million, a price-to-earnings ratio of 22.34 and a beta of 0.43. The firm has a 50 day moving average price of $31.08 and a two-hundred day moving average price of $32.87.

Institutional Trading of Roundhill GLP-1 & Weight Loss ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Osaic Holdings Inc. raised its holdings in Roundhill GLP-1 & Weight Loss ETF by 205.7% during the 2nd quarter. Osaic Holdings Inc. now owns 1,397 shares of the company’s stock worth $35,000 after purchasing an additional 940 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in shares of Roundhill GLP-1 & Weight Loss ETF in the 4th quarter valued at $68,000. Jane Street Group LLC boosted its stake in shares of Roundhill GLP-1 & Weight Loss ETF by 13.2% in the 1st quarter. Jane Street Group LLC now owns 73,545 shares of the company’s stock valued at $1,740,000 after purchasing an additional 8,579 shares during the last quarter. Finally, National Bank of Canada FI boosted its stake in shares of Roundhill GLP-1 & Weight Loss ETF by 6.1% in the 3rd quarter. National Bank of Canada FI now owns 84,152 shares of the company’s stock valued at $2,293,000 after purchasing an additional 4,808 shares during the last quarter.

About Roundhill GLP-1 & Weight Loss ETF

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.